Clinical Trial Update: A Clinical Study of GK02 in Malignant Ascites [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial investigates GK02 for malignant ascites caused by advanced solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites

Drugs mentioned

• GK02

Snippet

Sponsor: Beijing Geekgene Technology Co., LTD | Conditions: Malignant Ascites Caused by Advanced Solid Tumors | EARLY_Phase 1 | Status: RECRUITING